Androgens for Poor Responders in In Vitro Fertilization

Transdermal Testosterone to Improve Ovarian Response to Gonadotropins in Poor Responder IVF Patients With Normal Basal Concentrations of FSH

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00693108

Enrollment

Unknown

Registered

2008-06-06

Start date

2006-09-30

Completion date

Unknown

Last updated

2008-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Response

Keywords

Poor, Response, Ovarian, Stimulation, IVF, Patients

Brief summary

it has been shown that androgens in non human primates may favour follicular growth in the ovaries when animals are treated with gonadotropins which are the hormones used in patients receiving treatment with in vitro fertilization. Therefore, this study investigates the potential usefulness of testosterone treatment preceding gonadotropin administration in in vitro fertilization patients having a previous poor response to gonadotropins alone.

Interventions

DRUGTransdermal testosterone

Eligibility

Sex/Gender

FEMALE

Age

19 Years to 39 Years

Healthy volunteers

Inclusion criteria

* Patients receiving the second IVF treatment attempt having the first treatment cycle cancelled because of poor ovarian response to gonadotropins

Exclusion criteria

* Previous ovarian surgery * Clinical or laboratory profile suggesting premature ovarian failure

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026